88 related articles for article (PubMed ID: 11505321)
41. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
Fizazi K; Doubre H; Le Chevalier T; Riviere A; Viala J; Daniel C; Robert L; Barthélemy P; Fandi A; Ruffié P
J Clin Oncol; 2003 Jan; 21(2):349-54. PubMed ID: 12525529
[TBL] [Abstract][Full Text] [Related]
42. 24-hour cyclophosphamide infusion therapy for malignant mesothelioma of the pleura.
Anderson H; Hasleton P; Michie AB; Johnson RJ; Thatcher N
Br J Dis Chest; 1988 Jan; 82(1):64-9. PubMed ID: 3166920
[TBL] [Abstract][Full Text] [Related]
43. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response.
Stam TC; Swaak AJ; Kruit WH; Stoter G; Eggermont AM
Eur J Clin Invest; 2000 Apr; 30(4):336-43. PubMed ID: 10759883
[TBL] [Abstract][Full Text] [Related]
44. Response to chemotherapy of brain metastases from malignant pleural mesothelioma.
Colleoni M; Liessi G; Avventi C; Pancheri F; Sgarbossa G; Vicario G; Manente P
Tumori; 1996; 82(5):456-8. PubMed ID: 9063523
[TBL] [Abstract][Full Text] [Related]
45. Malignant pleural mesothelioma.
Rishikesh K; Kini U; Shenoy N; Joy B; D'Souza G; Shet A
J Assoc Physicians India; 2013 Aug; 61(8):576-9. PubMed ID: 24818349
[No Abstract] [Full Text] [Related]
46. Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.
Thatcher N; Taylor P; Carroll KB; Loriaux EM; Palmer P; Franks CR
Cancer Treat Rev; 1989 Jun; 16 Suppl A():161-2. PubMed ID: 2788503
[No Abstract] [Full Text] [Related]
47. Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future?
Munck C; Mordon SR; Scherpereel A; Porte H; Dhalluin X; Betrouni N
Ann Thorac Surg; 2015 Jun; 99(6):2237-45. PubMed ID: 25912746
[TBL] [Abstract][Full Text] [Related]
48. Combining chemotherapy with virotherapy: a novel treatment strategy for malignant pleural mesothelioma.
Curiel DT; Zhu ZB
Cancer Biol Ther; 2006 Feb; 5(2):236-7. PubMed ID: 16481733
[No Abstract] [Full Text] [Related]
49. Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma.
Markman M; Cleary S; Pfeifle C; Howell SB
Cancer; 1986 Jul; 58(1):18-21. PubMed ID: 3708543
[TBL] [Abstract][Full Text] [Related]
50. The therapeutic implications of the genomic analysis of malignant pleural mesothelioma.
Zauderer MG
Nat Commun; 2021 Mar; 12(1):1819. PubMed ID: 33753750
[TBL] [Abstract][Full Text] [Related]
51. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
Karrison TG; Vogelzang NJ
Cancer; 1999 Aug; 86(3):546-7. PubMed ID: 10430267
[No Abstract] [Full Text] [Related]
52. Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases.
Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE
Lung Cancer; 2004 Jan; 43(1):71-4. PubMed ID: 14698539
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin.
Harvey VJ; Slevin ML; Ponder BA; Blackshaw AJ; Wrigley PF
Cancer; 1984 Sep; 54(6):961-4. PubMed ID: 6467141
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy of malignant mesothelioma.
Gerner RE; Moore GE
Oncology; 1974; 30(2):152-5. PubMed ID: 4217436
[No Abstract] [Full Text] [Related]
55. [Intrapleural injection of hyaluronidase in mesothelioma].
Mulliez P; Regdosz R; Forzy G; Crinquette J
Presse Med; 1985 Jun; 14(25):1383. PubMed ID: 3161033
[No Abstract] [Full Text] [Related]
56. Implantable access system for prolonged intrapleural immunotherapy.
Driesen P; Boutin C; Viallat JR; Astoul PH; Vialette JP; Pasquier J
Eur Respir J; 1994 Oct; 7(10):1889-92. PubMed ID: 7828700
[TBL] [Abstract][Full Text] [Related]
57. Oral etoposide in the treatment of malignant mesothelioma. A phase II study.
Tammilehto L; Maasilta P; Mäntylä M; Salo J; Mattson K
Ann Oncol; 1994 Dec; 5(10):949-50. PubMed ID: 7696167
[No Abstract] [Full Text] [Related]
58. Regional pharmacokinetic selectivity of intrapleural cisplatin.
Bogliolo GV; Lerza R; Bottino GB; Mencoboni MP; Pannacciulli IM; Vannozzi M; Fulco RA; Merlo F; Esposito M
Eur J Cancer; 1991; 27(7):839-42. PubMed ID: 1834113
[TBL] [Abstract][Full Text] [Related]
59. Cerebral metastases in malignant mesothelioma: a case report.
Cheeseman SL; Ranson MR
Eur J Cancer Care (Engl); 1999 Jun; 8(2):104-6. PubMed ID: 10476113
[TBL] [Abstract][Full Text] [Related]
60. Early chemotherapy for patients with mesothelioma.
Srinivasan S
Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
